Effects of Exercise on Thyroid Stimulating Hormone Among Class-I Obese Patients With Diabetes Mellitus and Lipid Disorders

November 1, 2023 updated by: Batool Hassan, Ziauddin University

Obesity is characterized by an excessive accumulation of body fat that gives rise to significant comorbidities, such as diabetes, hypertension, dyslipidemia, cardiovascular disease, and many cancers. According to WHO, Obesity is a worldwide epidemic, with an estimated 57.8% of adults worldwide expected to be classified as obese by 2030. Therefore, obesity is invariably referred to as a crucial public health problem that requires urgent attention to prevent obesity-related health outcomes. Thyroid dysfunction is often accompanied by changes in body weight and body composition, leading to obesity.

The rising risk of obesity has created susceptibility for every individual irrespective of age, gender and demography. Hence, the focus of researchers is now shifting to devising preventive strategies from the treatment approaches for obesity. To guide healthcare professionals in treating obesity, several guidelines from The Obesity Society (TOS) have been prepared that outline multiple therapies like lifestyle modifications, increased physical activities, dietary modifications, use of medications and in some cases, even surgeries are recommended. However, poor receptivity of exercise among the general population required healthcare professionals to design an exercise program that could be cost and time-effective for the patient. Hence, the present study aims to determine the effect of exercise and the documentation of the best possible exercise regime that could increase TSH among the class I obese population.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study is a randomized controlled trial. The participants were recruited via the envelop method of simple random sampling technique into four groups: Moderate Intensity Continuous Training (MICT), Resistance Training (RT), High-Intensity Interval Training (HIIT) and ½ HIIT.

The training was based on a warm-up session of 5 to 10 minutes followed by conditioning and a cool-down phase of 5 to 10 minutes. The detailed description of each phase is as follows:

Warmup Warm-up exercises, including High Knee and Jumping Jack Exercises, were performed 5 to 10 minutes using the Lindstrom protocol to increase core body temperature and improve blood.

Conditioning Conditioning includes exercises that were performed by the participants under the supervision of a Qualified senior Physical Therapist for varied duration of time depending on the protocol of training.

Moderate Intensity Continuous Training Moderate-intensity endurance exercises were performed by the participants under the supervision of a Qualified senior Physical Therapist by using either a treadmill or cycle ergometer. Exercise frequency was 3 days per week for 16 weeks, each session lasting for 30 minutes. The intensity was calculated using the Karovonean method10, in which a targeted heart rate of 60-85% was maintained for the purpose of conditioning.

THR= (MHR-RHR x Training %) + RHR

Resistance Exercise Conditioning using resistance exercises involves training of 11 major muscle groups of the body that include i) biceps, ii) triceps, iii) deltoid, iv) trapezius, v) latisimus dorsi, vi) pectoralis major vii) abdominals, viii) back extensors, ix) hamstrings, x) quadriceps, and xi) calf (WLC). The protocol included strengthening exercise with an intensity calculated by 1 Repetition maximum method technique11. Exercises were performed three days/ week (every alternate day), and the time required for single-day training is the time needed to complete 3 sets of 10 repetitions of each major muscle group.

High-Intensity Interval Training The HIIT protocol consisted of 10 s of the sprint, working at 85%- 90% of HRmax and 10 s of the recovery phase, during which participants cycled as slowly as possible for a total duration of 20 minutes. Participants were instructed when to start and stop in each phase. The duration of the exercise session was calculated for each participant individually.

1/2- High-Intensity Interval Training Participants in the 1/2-HIIT group followed the same protocol as the HIIT group, but only for the duration of 10 minutes working at 85%- 90% of HRmax of 12 s of sprint and 8 s of recovery phase.

Cool Down The cool-down session lasted for 5-10 minutes. During the period, full-body stretches were performed with low-intensity, long-hold stretching.

Exercise Termination Criteria

The exercise session was prematurely terminated on the occurrence of one of the following:

  • Modified Borg dyspnea scale (RPP) at level 8 or above.
  • Decrease in oxygen saturation<90%.
  • Any complaints of chest pain, leg cramps, palpitation or tiredness by the patient.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan
        • Ziauddin University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Class I obese population BMI ≥25.0 -30.0
  • Young adults aged 20-40 years
  • Diagnosed patients with DM and dyslipidemia.

Exclusion Criteria:

-Patients diagnosed with pre-existing heart conditions, major illness (acute or chronic), beta-blockers, pregnant or lactating women, and smokers, including any that would limit the ability to perform the necessary exercises, will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Moderate Intensity Continuous Training
Effects of exercises on TSH levels
Active Comparator: Resistance Training
Effects of exercises on TSH levels
Active Comparator: High-Intensity Interval Training
Effects of exercises on TSH levels
Active Comparator: 1/2- High-Intensity Interval Training
Effects of exercises on TSH levels

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thyroid Stimulating Hormone
Time Frame: 16 weeks
The levels of TSH were measured using blood sample (Biodata Diagnostic brand RIA kit)12. The samples were taken twice once before the start of the training protocol and second after the completion of 16 weeks of training. The difference in the values between the groups was used to evaluate the impact of exercises thyroid hormone levels in the body.
16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2021

Primary Completion (Actual)

July 15, 2023

Study Completion (Actual)

October 2, 2023

Study Registration Dates

First Submitted

November 1, 2023

First Submitted That Met QC Criteria

November 1, 2023

First Posted (Actual)

November 7, 2023

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 1, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Exercise

Subscribe